YiPSCELL is Korean start-up based on induced pluripotent stem cell technology. YiPSCELL produce stem cell lines derived from normal humans and patient using the next generation stem cell technology called “induced pluripotent stem cell” and produce disease modeling platform services that can replace animal experiments.
YiPSCELL
Category:
Venture
Main Business Area
YiPSCELL conducts clinical immunology & stem cell research and aims to proceed induced pluripotent stem cell research and develop therapeutics based on our research.
| Contact Details | L2, Omnibus Park, Banpo-dearo 222, Seocho-gu, Seoul +82 (2) 1522 3325support@yipscell.com |
|---|
